Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Phase: Phase 1"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%22&lookfor=%22WHO+International+Clinical+Trials+Registry+Platform%22&type=JournalTitle&page=9
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%22&lookfor=%22WHO+International+Clinical+Trials+Registry+Platform%22&type=JournalTitle&page=9
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+1%22&lookfor=%22WHO+International+Clinical+Trials+Registry+Platform%22&type=JournalTitle&page=9
PubPharm (23.376)
81
An Open-label, Multiple-site, Phase I/II Dose Cohort Trial of [6R] 5,10-Methylene Tetrahydrofolate (Modufolin®) in Combination with a Fixed Dose of 5-Fluorouracil (5-FU) alone or together with a Fixed Dose of Oxaliplatin or Irinotecan in Patients with Stage IV Colorectal Cancer : An Open-label, Multiple-site, Phase I/II Dose Cohort Trial of [6R] 5,10-Methylene Tetrahydrofolate (Modufolin®) in Combination with a Fixed Dose of 5-Fluorouracil (5-FU) alone or together with a Fixed Dose of Oxaliplatin or Irinotecan in Patients with Stage IV Colorectal Cancer
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
82
FaR-RMS: An overarching study for children and adults with Frontline and Relapsed RhabdoMyoSarcoma : FaR-RMS: An overarching study for children and adults with Frontline and Relapsed RhabdoMyoSarcoma - FaR-RMS
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
83
Study into the safety and activity of the drug Crizotinib for children with malignant tumors : A phase 1B of crizotinib either in combination or as single agent in pediatric patients with ALK, ROS1 or MET positive malignancies - CRISP
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
84
A Study of BMS-813160 in Combination with Chemotherapy or Nivolumab in Patients with Advanced Solid Tumors : A Phase 1b/2 Study of BMS-813160 in Combination with Chemotherapy or Nivolumab in Patients with Advanced Solid Tumors.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
85
A Phase 1/2 Multicenter Study of KTE-X19 in Adult Subjects with Relapsed/Refractory Chronic Lymphocytic Leukemia. : Phase 1/2 Multicenter Study Evaluating the Safety and Efficacy of KTE-X19 in Adult Subjects with Relapsed/Refractory Chronic Lymphocytic Leukemia - ZUMA-8
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
86
A Pharmacokinetic, Pharmacodynamic, and Safety Study of Etrolizumab Followed by Open-Label Extension and Safety Monitoring in Pediatric Patients From 4 Years to Less Than 18 Years of Age with Moderate to Severe Ulcerative Colitis or Moderate to Severe Crohn’s Disease : A PHASE I, OPEN–LABEL, RANDOMIZED, PHARMACOKINETIC, PHARMACODYNAMIC, AND SAFETY STUDY OF ETROLIZUMAB FOLLOWED BY OPEN–LABEL EXTENSION AND SAFETY MONITORING IN PEDIATRIC PATIENTS FROM 4 YEARS TO LESS THAN 18 YEARS OF AGE WITH MODERATE TO SEVERE ULCERATIVE COLITIS OR MODERATE TO SEVERE CROHN’S DISEASE
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
87
Clinical Trial to evaluate the safety and efficacy of oral treatment with OST-122 in patients with moderate to severe ulcerative colitis : A Phase Ib/IIa, randomized, double blind, placebo controlled, multicenter clinical trial to evaluate the safety, pharmacokinetics and efficacy of oral treatment with OST-122 in patients with moderate to severe ulcerative colitis
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
88
A study evaluating safety and efficacy of Itacitinib in combination with corticosteroids for the treatment of first-line acute graft versus-host disease in children : An Open-Label, Single-Arm, Phase 1/2 Study Evaluating the Safety and Efficacy of Itacitinib in Combination With Corticosteroids for the Treatment of Steroid-Naive Acute Graft-Versus-Host Disease in Pediatric Subjects
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
89
A study of the investigational drug MCLA-128 which is an antibody that isspecific to both HER2 and HER3 receptors that are associated with solidtumors : A Phase I/II Study of MCLA-128, a full length IgG1 Bispecific Antibody Targeting HER2 and HER3, in Patients with Solid Tumors
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
90
study to assess how safe and how effective is Loncastuximab Tesirine together with Ibrutinib in patients with Advanced Diffuse Large B Cell Lymphoma or Mantle Cell Lymphoma : A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of Loncastuximab Tesirine and Ibrutinib in Patients with Advanced Diffuse Large B-Cell Lymphoma or Mantle Cell Lymphoma
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
[1]
« Vorheriger
4
5
6
7
8
9
10
11
12
13
14
Nächster »
[2338]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Phase: Phase 1
Medienart
23.376
Aufsätze
23.376
E-Artikel
23.376
E-Ressourcen
Zeitschriftentitel
23.376
WHO International Clinical Trials Registry Plat...
Thema
23.376
610
Phase: Phase 1
21.248
Study Type: Interventional
8.476
Recruitment Status: Not yet recruiting
5.910
Recruitment Status: Completed
3.278
Recruitment Status: Authorised-recruitment may ...
3.166
Recruitment Status: Recruiting
1.454
Study Type: Observational
1.114
Recruitment Status: Complete: follow-up complete
226
Medical Condition: ;Not Applicable
196
Recruitment Status: Active, not recruiting
182
Recruitment Status: Complete: follow-up continuing
180
Study Type: BA/BE
140
Recruitment Status: Closed to Recruitment of Pa...
124
Study Type: Relative factors research
120
Recruitment Status: Stopped early
92
Medical Condition: ;Diseases of the circulatory...
90
Study Type: Diagnostic test
82
Recruitment Status: Withdrawn
80
Medical Condition: ;Neoplasms
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
15.784
2020-
7.592
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
23.080
Englisch
234
Unbestimmt
20
Spanisch
12
Französisch
6
Niederländisch
6
Italienisch
4
Deutsch
2
Dänisch
2
Finnisch
2
Norwegisch
2
Nyanja
2
Sanskrit
2
Schwedisch
2
Xhosa
Alle anzeigen ...
weniger ...
Haven't found what you're looking for?
Wird geladen...